COR

Cencora Inc.

COR.US cencora.com
320.95
-2.37 (-0.73%)
USD · NYSE
52-week range
243.78
375.33
Trading at 59% of the 52-week range
Market Cap
61.70B
P/E Ratio
24.00
Forward P/E
16.31
Book Value
15.99
Div. Yield
0.72%
% Institutions
99.72%
% Insiders
4.30%

1 Year

+9.1%

3 Year

+85.2%

10 Year

+402.1%
Description

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Company Information

Company Name
Cencora Inc.
Sector
Healthcare
Industry
Medical Distribution
Exchange
NYSE
ISIN: US03073E1055
CIK: 0001140859
CUSIP: 03071P102
Currency: USD
Full Time Employees: 47,000
Phone: 610 727 7000
Website: cencora.com
Fiscal Year End: September
IPO Date: Apr 04, 1995
Description:

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Address:

1 West First Avenue, Conshohocken, PA, United States, 19428-1800

People

Directors & Officers

Name Title Year Born
Dr. Robert P. Mauch Ph.D., PharmD President, CEO & Director 1967
Ms. Elizabeth S. Campbell J.D. Executive VP & Chief Legal Officer 1975
Mr. James F. Cleary Jr. Advisor 1963
Ms. Silvana Battaglia Advisor 1968
Ms. Eva C. Boratto Executive VP & CFO 1967
Mr. Lazarus Krikorian Senior VP, Chief Accounting Officer & Corporate Controller 1965
Mr. Pawan Singh Verma Executive VP and Chief Data & Information Officer 1977
Mr. Bennett S. Murphy Senior VP Of Investor Relations & Enterprise Productivity and Treasury NA
Ms. Samantha L. Hammock Executive VP & Chief Human Resources Officer 1979
Mr. Richard Tremonte EVP and President of U.S. Pharmaceuticals & Animal Health NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 30, 2026 Ro Khanna N/A Sale N/A $309.84 N/A
Mar 23, 2026 Ro Khanna N/A Sale N/A $320.68 N/A
Jan 29, 2026 Ro Khanna N/A Purchase N/A $351.49 N/A
Jan 20, 2026 Robert P Mauch N/A Sale 5.10K $354.73 $1.81M
Dec 19, 2025 Elizabeth S Campbell N/A Sale 3.35K $342.10 $1.15M
Dec 19, 2025 Silvana Battaglia N/A Sale 1.68K $345.00 $578.57K
Dec 18, 2025 Robert P Mauch N/A Sale 5.10K $343.45 $1.75M
Nov 18, 2025 Robert P Mauch N/A Sale 5.10K $366.64 $1.87M
Oct 27, 2025 Michael T. McCaul N/A Sale N/A $336.00 N/A
Oct 20, 2025 Robert P Mauch N/A Sale 5.10K $326.80 $1.67M
Sep 18, 2025 Robert P Mauch N/A Sale 5.10K $290.00 $1.48M
Sep 16, 2025 Steven H Collis N/A Sale 31.35K $289.86 $9.09M
Aug 22, 2025 Michael T. McCaul N/A Sale N/A $292.25 N/A
Aug 07, 2025 Michael T. McCaul N/A Sale N/A $278.18 N/A
Jul 22, 2025 Steven H Collis N/A Sale 14.58K $292.67 $4.27M
Jul 18, 2025 Robert P Mauch N/A Sale 4.97K $294.11 $1.46M
Jun 27, 2025 Michael T. McCaul N/A Sale N/A $299.71 N/A
Jun 24, 2025 Steven H Collis N/A Sale 14.58K $292.62 $4.27M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 19.94M Mar 31, 2026 10.45% $0.11 -1.69%
Vanguard Capital Management, LLC 12.31M Mar 31, 2026 6.45% $0.10 0.00%
Vanguard Portfolio Management, LLC 9.59M Mar 31, 2026 5.03% $0.16 0.00%
State Street Corp 9.19M Mar 31, 2026 4.82% $0.10 -1.24%
T. Rowe Price Associates, Inc. 7.32M Mar 31, 2026 3.84% $0.27 4.73%
FMR Inc 6.69M Mar 31, 2026 3.50% $0.11 22.47%
T. Rowe Price Investment Management,Inc. 6.29M Mar 31, 2026 3.30% $1.36 -44.60%
Geode Capital Management, LLC 5.57M Mar 31, 2026 2.92% $0.11 1.95%
JPMorgan Chase & Co 4.89M Mar 31, 2026 2.56% $0.10 -1.95%
Wellington Management Company LLP 4.56M Jun 30, 2026 2.39% $0.22 0.25%
Morgan Stanley - Brokerage Accounts 4.53M Mar 31, 2026 2.37% $0.09 54.95%
Boston Partners Global Investors, Inc 4.48M Mar 31, 2026 2.35% $1.48 6.82%
Bank of America Corp 4.14M Mar 31, 2026 2.17% $0.10 6.91%
Amvescap Plc. 3.99M Mar 31, 2026 2.09% $0.12 1.84%
NORGES BANK 2.47M Jun 30, 2026 1.30% $0.07 1.58%
The Goldman Sachs Group Inc 2.21M Mar 31, 2026 1.16% $0.08 3.99%
Northern Trust Corp 2.18M Mar 31, 2026 1.14% $0.09 -1.85%
Capital Research Global Investors 1.98M Jun 30, 2026 1.04% $0.08 1.04%
Dimensional Fund Advisors, Inc. 1.64M Jun 30, 2026 0.86% $0.08 5.90%
UBS Asset Mgmt Americas Inc 1.62M Mar 31, 2026 0.85% $0.11 2.19%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 5.89M 3.08% ▲ 0.28% Jul 31, 2026
2 Vanguard 500 Index Investor 5.11M 2.68% ▲ 1.06% Jul 31, 2026
3 T. Rowe Price Capital Appreciation 4.69M 2.46% ▲ 3.91% Jul 31, 2026
4 Vanguard MStar Mid Cap Index Instl 4.00M 2.10% ▼ 0.14% Jul 31, 2026
5 Vanguard Health Care Inv 2.84M 1.49% ▲ 20.19% Jun 30, 2026
6 iShares Core S&P 500 ETF 2.59M 1.36% ▼ 0.16% Aug 31, 2026
7 Fidelity 500 Index 2.52M 1.32% ▲ 0.80% Jul 31, 2026
8 State Street® SPDR® S&P 500® ETF 2.39M 1.25% ▲ 0.02% Aug 31, 2026
9 Vanguard MStar Value Index Investor 1.76M 0.92% ▲ 0.22% Jul 31, 2026
10 T. Rowe Price U.S. Value Equity Tr-D 1.62M 0.85% ▼ 15.45% Jun 30, 2026

Financial Highlights

Market Cap: $61.70B
EBITDA: $5.55B
P/E Ratio: $24.00
PEG Ratio: $0.68
Book Value: $15.99
Dividend/Share: $2.35
Dividend Yield: 0.72%
Earnings/Share: $13.47
Profit Margin: 0.79%
Operating Margin: 1.41%
ROA (TTM): 3.56%
ROE (TTM): 96.87%
Revenue (TTM): $332.77B
Revenue/Share (TTM): $1.72K
Earnings Growth (YOY): 11.90%
Revenue Growth (YOY): 5.10%

Valuation Metrics

Enterprise Value: $70.87B
Trailing P/E: 24.00
Forward P/E: 16.31

Shares Statistics

Shares Outstanding: 190.83M
Shares Float: 180.25M
% Insiders: 4.30%
% Institutions: 99.72%
Short % Float: 2.77%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$321.33B
Cost of Goods Sold
adjust
$-311.19B
Gross Profit
subtotal
$10.14B
SG&A
adjust
$-6.49B
Operating Income
subtotal
$3.65B
Other / Non-Operating Items
adjust
$-2.09B
Net Income
subtotal
$1.55B

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about COR.US!